SHERMAN JEFFREY W

CIK 00012304823 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001230482

Recent Transactions

39 trades

Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-06-04+50,000→ 214,380 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-06-04+50,000→ 214,380 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-06-05+50,000→ 164,380 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-06-05+50,000→ 164,380 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-21+5,354→ 61,665 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-21$86.42/sh−2,372→ 59,293 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2022-01-21−5,354→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2022-01-21−5,354→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-21+5,354→ 61,665 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-21$86.42/sh−2,372→ 59,293 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-21$86.42/sh−2,372→ 59,293 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2022-01-21−5,354→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-21+5,354→ 61,665 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-21$86.42/sh−2,372→ 59,293 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2022-01-21−5,354→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-21+5,354→ 61,665 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2017-01-02$16.18/sh−12,602→ 181,898 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2017-01-02−11,250→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2017-01-02−15,500→ 15,500 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2017-01-02+26,750→ 194,500 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2017-01-02−11,250→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2017-01-02−15,500→ 15,500 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2017-01-02$16.18/sh−12,602→ 181,898 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2017-01-02+26,750→ 194,500 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2016-01-02−15,500→ 31,000 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2016-01-02$21.67/sh−8,576→ 153,748 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2016-01-02−11,250→ 11,250 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2016-01-02+26,750→ 162,324 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2016-01-02−15,500→ 31,000 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2016-01-02+26,750→ 162,324 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2016-01-02$21.67/sh−8,576→ 153,748 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2016-01-02−11,250→ 11,250 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted stock units
2015-01-02−15,500→ 46,500 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted stock units
2015-01-02−11,250→ 22,500 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary shares
2015-01-02$12.80/sh−8,753→ 102,333 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary shares
2015-01-02+26,750→ 111,086 total
Purchase
NEOPHARM INC
Common
2006-09-27$4.98/sh+1,000→ 3,281 total
Award
NEOPHARM INC
Common
2005-04-28$7.95/sh+29,100→ 29,100 total
Award
NEOPHARM INC
Common
2005-04-28$7.95/sh+29,100→ 29,100 total

Companies

Recent Filings

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607

View on SEC.gov